Private equity firm Carlyle to buy a fifth of Piramal Ent’s pharma business for nearly $490 million – Moneycontrol

The transaction values the Piramal Pharma at an enterprise value (EV) of $2.77 billion with an upside component of up to $360 million depending on the company?s FY21 performance. Read More